Mitotic activation: A convergent mechanism for a cohort of neurodegenerative diseases

Neurobiology of Aging

Volumn 21, Issue 6, 2000, Pages 815-828

  Husseman, J W ^a   Nochlin, D ^a   Vincent, I ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Alzheimer's disease; cdc2; Cell cycle; Corticobasal degeneration; Cyclin B1; Frontotemporal dementia; H5; Mitosis; MPM 2; Neurodegeneration; Neurofibrillary tangles; Neuronal death; Niemann Pick disease type C; Parkinson amyotrophic lateral sclerosis of Guam; Pick's disease; Progressive supranuclear palsy; TG 3

Indexed keywords

CYCLIN B1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; EPITOPE; NUCLEOLIN; PHOSPHOPROTEIN; RNA POLYMERASE II; TAU PROTEIN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN INJURY; BRAIN TISSUE; CELL ACTIVATION; CELL CYCLE; CONFOCAL MICROSCOPY; CORTICOBASAL DEGENERATION; DEGENERATIVE DISEASE; DOWN SYNDROME; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MALE; MITOSIS; NIEMANN PICK DISEASE; PARKINSONISM; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SIGNAL TRANSDUCTION;

ADULT; AGED; AGED, 80 AND OVER; AIDS DEMENTIA COMPLEX; ALZHEIMER DISEASE; BRAIN; CELL CYCLE; CYCLIN-DEPENDENT KINASES; CYCLINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOSIS; MOTOR NEURON DISEASE; NEURODEGENERATIVE DISEASES; REFERENCE VALUES; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 0033635551     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(00)00221-9     Document Type: Article

References (88)

1. Ubiquitin, cellular inclusions and their role in neurodegeneration
2. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease
3. Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer's disease
4. The fission yeast cdc2/cdc13/suc1 protein kinase; regulation of catalytic activity and nuclear localization
5. c-Myc cooperates with activated Ras to induce the cdc2 promoter
6. Neuropathological stageing of Alzheimer-related changes
7. The tau proteins in neuronal growth and development
8. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease
9. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain
10. Parkinson's disease, motoneuron disease and Alzheimer's disease; origins and interrelationship
11. Upstream stimulatory factor regulates expression of the cell cycle-dependent cyclin B1 gene promoter
12. Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle
13. Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease
14. Monoclonal antibodies to mitotic cells
15. Pick's disease; a modern approach
16. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration
17. Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes
18. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients
19. The multifunctional TFIIH complex and transcriptional control
20. Partially processed pre-rRNA is preserved in association with processing components in nucleolus-derived foci during mitosis
21. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum; implications for Alzheimer's disease
22. Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration; differentiation from progressive supranuclear palsy
23. The Lewy-body variant of Alzheimer's disease. Clinical and pathological findings
24. Over-expression and amplification of the CDC2 gene in leukaemia cells
25. Phosphorylation of the carboxy-terminal repeat domain in RNA polymerase II by cyclin-dependent kinases is sufficient to inhibit transcription
26. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
27. Regional and neuronal reductions of polyadenylated messenger RNA in Alzheimer's disease
28. Mitotic repression of transcription in vitro
29. Checkpoints; controls that ensure the order of cell cycle events
30. Amyotrophic lateral sclerosis and parkinsonism-dementia complex on Guam; immunohistochemical studies
31. TFIIH; a key component in multiple DNA transactions
32. Hippocampal and entorhinal cortex cellular pathology in Alzheimer's disease
33. A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease
34. p34(Cdc2) kinase activity is excluded from the nucleus during the radiation-induced G(2) arrest in HeLa cells
35. Hereditary cancer; two hits revisited
36. Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes
37. cdc25 is one of the MPM-2 antigens involved in the activation of maturation-promoting factor
38. Parkinson's disease in patients with Alzheimer's disease
39. Nuclear localization of cyclin B1 mediates its biological activity and is regulated by phosphorylation
40. Familial and sporadic Alzheimer's disease; neuropathology cannot exclude a final common pathway
41. Ballooned neurons in several neurodegenerative diseases and stroke contain alpha B crystallin
42. Ubiquitin in neurodegenerative diseases
43. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein
44. A spatial gradient of tau protein phosphorylation in nascent axons
45. Nerve cell protein metabolism and degenerative disease
46. Cytophotometric mapping of neuronal changes in senile dementia
47. Transcriptional and translational regulatory mechanisms during normal aging of the mammalian brain and in Alzheimer's disease
48. Immunoreactivity of the nuclear antigen p105 is associated with plaques and tangles in Alzheimer's disease
49. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau
50. Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex
51. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease
52. Components of the nucleolar processing complex (Pre-rRNA, fibrillarin, and nucleolin) colocalize during mitosis and are incorporated to daughter cell nucleoli
53. Activation of cyclin A-dependent protein kinases during apoptosis
54. Apoptosis and the cell cycle
55. Nuclear import of Cdk/cyclin complexes; identification of distinct mechanisms for import of Cdk2/cyclin E and Cdc2/cyclin B1
56. Cell cycle regulation of a Xenopus Wee1-like kinase
57. Cell cycle markers in the hippocampus in Alzheimer's disease
58. Role of cell cycle regulatory proteins in cerebellar granule neuron apoptosis
59. G1 events and regulation of cell proliferation
60. Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents
61. Multiple pathways of neuronal death induced by DNA-damaging agents, NGF deprivation, and oxidative stress
62. Cyclins A and B1 in the human cell cycle
63. Tau is a candidate gene for chromosome 17 frontotemporal dementia
64. Synthesis of RNA and protein during mitosis in mammalian tissue culture cells
65. The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells
66. Lewy bodies in the presence of Alzheimer's disease
67. Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders
68. Immunocytochemical study of ballooned neurons in cortical degeneration with neuronal achromasia
69. Frontotemporal dementia and Parkinsonism linked to chromosome 17; a new group of tauopathies
70. Chemically induced premature mitosis; differential response in rodent and human cells and the relationship to cyclin B synthesis and p34cdc2/cyclin B complex formation
71. Familial presenile dementia with psychosis associated with cortical neurofibrillary tangles and degeneration of the amygdala
72. Neurofibrillary tangles in Niemann-Pick disease type C
73. Specific association of an M-phase kinase with isolated mitotic spindles and identification of two of its substrates as MAP4 and MAP1B
74. Mechanisms of neuronal degeneration; a final common pathway?
75. Nucleolin; a multifunctional major nucleolar phosphoprotein
76. Microtubule-associated protein MAP1B showing a fetal phosphorylation pattern is present in sites of neurofibrillary degeneration in brains of Alzheimer's disease patients
77. Proteins of the mammalian mitotic spindle; phosphorylation/dephosphorylation of MAP-4 during mitosis
78. Distribution of cytoskeletal proteins sharing a conserved phosphorylated epitope
79. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain
80. Mitotic mechanisms in Alzheimer's disease?
81. Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease
82. Anti-immunoglobulin treatment of murine B-cell lymphomas induces active transforming growth factor beta but pRB hypophosphorylation is transforming growth factor beta independent
83. Cytostellin; a novel, highly conserved protein that undergoes continuous redistribution during the cell cycle
84. A possible mechanism for the inhibition of ribosomal RNA gene transcription during mitosis